ArticleFrontiers in pharmacology2025
Real-world study on adverse drug reactions of pembrolizumab in endometrial cancer treatment: insights from the FAERS database.
Huiping Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it